{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:59Z","timestamp":1786372919976,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.2215\/cjn.07131009","type":"journal-article","created":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T22:51:13Z","timestamp":1262904673000},"page":"299-306","source":"Crossref","is-referenced-by-count":63,"title":["A Randomized Trial of Cholecalciferol versus Doxercalciferol for Lowering Parathyroid Hormone in Chronic Kidney Disease"],"prefix":"10.2215","volume":"5","author":[{"given":"Sharon M.","family":"Moe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akber","family":"Saifullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"LaClair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail A.","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangsheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20230601","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2215\/CJN.05781207","article-title":"Hypovitaminosis D in chronic kidney disease","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-25-20230601","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R3-25-20230601","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S8756-3282(02)00692-0","article-title":"Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III","volume":"30","author":"Looker","year":"2002","journal-title":"Bone"},{"key":"R4-25-20230601","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1359\/jbmr.060803","article-title":"25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease","volume":"21","author":"Elder","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R5-25-20230601","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Am J Nephrol"},{"key":"R6-25-20230601","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"R7-25-20230601","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1440-1797.2007.00860.x","article-title":"Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4","volume":"13","author":"Stavroulopoulos","year":"2008","journal-title":"Nephrology (Carlton"},{"key":"R8-25-20230601","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bone.2008.11.016","article-title":"Serum 25-hydroxyvitamin D as an independent determinant of 1\u201384 PTH and bone mineral density in non-diabetic predialysis CKD patients","volume":"44","author":"Tomida","year":"2009","journal-title":"Bone"},{"key":"R9-25-20230601","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2008.4","article-title":"Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease","volume":"73","author":"Gutierrez","year":"2008","journal-title":"Kidney Int"},{"key":"R10-25-20230601","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1001\/jama.294.18.2336","article-title":"Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake","volume":"294","author":"Steingrimsdottir","year":"2005","journal-title":"JAMA"},{"key":"R11-25-20230601","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bone.2007.10.003","article-title":"Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake","volume":"42","author":"Adami","year":"2008","journal-title":"Bone"},{"key":"R12-25-20230601","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.ackd.2006.10.002","article-title":"Management of chronic kidney disease-mineral bone disorder","volume":"14","author":"Fadem","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"R13-25-20230601","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1677\/jme.0.0250141","article-title":"1alpha-Hydroxylase and the action of vitamin D","volume":"25","author":"Hewison","year":"2000","journal-title":"J Mol Endocrinol"},{"key":"R14-25-20230601","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ndt\/gfi186","article-title":"The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells","volume":"21","author":"Brown","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R17-25-20230601","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00004872-199816060-00002","article-title":"Self-monitoring of blood pressure at home: How many measurements are needed?","volume":"16","author":"Stergiou","year":"1998","journal-title":"J Hypertens"},{"key":"R19-25-20230601","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/j.ajkd.2004.12.021","article-title":"Quality of life in chronic kidney disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study","volume":"45","author":"Perlman","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R20-25-20230601","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/j.ajkd.2004.01.012","article-title":"Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4","volume":"43","author":"Coburn","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R21-25-20230601","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","article-title":"Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD","volume":"50","author":"Al-Aly","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R22-25-20230601","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000098561","article-title":"Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease","volume":"27","author":"Zisman","year":"2007","journal-title":"Am J Nephrol"},{"key":"R23-25-20230601","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4158\/EP.14.1.10","article-title":"Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: A randomized controlled pilot study","volume":"14","author":"Chandra","year":"2008","journal-title":"Endocr Pract"},{"key":"R24-25-20230601","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ki.1979.25","article-title":"Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization","volume":"15","author":"Fournier","year":"1979","journal-title":"Kidney Int"},{"key":"R25-25-20230601","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","article-title":"25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"50","author":"de Boer","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R26-25-20230601","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-8227(97)00090-9","article-title":"Alterations in serum levels of 1 alpha,25(OH)2 D3 and osteocalcin in patients with early diabetic nephropathy","volume":"38","author":"Inukai","year":"1997","journal-title":"Diabetes Res Clin Pract"},{"key":"R27-25-20230601","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF03343541","article-title":"Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria","volume":"22","author":"Verrotti","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"R28-25-20230601","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1053\/j.ajkd.2007.12.038","article-title":"Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: An uncontrolled trial","volume":"51","author":"Szeto","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R29-25-20230601","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: A randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"R30-25-20230601","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"key":"R32-25-20230601","first-page":"1633","article-title":"Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women","volume":"86","author":"Pfeifer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-25-20230601","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/HYPERTENSIONAHA.108.114991","article-title":"Effect of calcium and vitamin D supplementation on blood pressure: The Women's Health Initiative Randomized Trial","volume":"52","author":"Margolis","year":"2008","journal-title":"Hypertension"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201002000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:18Z","timestamp":1786369158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201002000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.07131009","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}